Then, we performed qRT-PCR and found that the relative expression of METTL16 and YTHDF3 mRNAs in patients with HbH and HbH-CS diseases was lower than that in normal controls without thalassemia (Fig 1a and 1b). The gene discussed is HBA2; the disease is thalassemia.